Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial.

MLA

Benhamou, Pierre-Yves, et al. “Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes in Real-Life Conditions: A 12-Week Multicentre, Open-Label Randomised Controlled Crossover Trial.” The Lancet. Digital Health, vol. 1, no. 1, May 2019, pp. e17–25. EBSCOhost, https://doi.org/10.1016/S2589-7500(19)30003-2.

APA

Benhamou, P.-Y., Franc, S., Reznik, Y., Thivolet, C., Schaepelynck, P., Renard, E., Guerci, B., Chaillous, L., Lukas-Croisier, C., Jeandidier, N., Hanaire, H., Borot, S., Doron, M., Jallon, P., Xhaard, I., Melki, V., Meyer, L., Delemer, B., Guillouche, M., … Charpentier, G. (2019). Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial. The Lancet. Digital Health, 1(1), e17–e25. https://doi.org/10.1016/S2589-7500(19)30003-2

Chicago

Benhamou, Pierre-Yves, Sylvia Franc, Yves Reznik, Charles Thivolet, Pauline Schaepelynck, Eric Renard, Bruno Guerci, et al. 2019. “Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes in Real-Life Conditions: A 12-Week Multicentre, Open-Label Randomised Controlled Crossover Trial.” The Lancet. Digital Health 1 (1): e17–25. doi:10.1016/S2589-7500(19)30003-2.